# Sentigraph 9A-1 Actual Evidence Layer Write / Production EvidenceItem Go-No-Go Gate Decision v0.1

## Decision

- phase = 9A-1
- decision = ready
- privacy_issue_stop = no
- docs_only = yes
- go_no_go_gate_decision_only = yes
- authorization_protocol_planning_only = yes
- implementation_performed = no
- backend_code_changed = no
- tests_changed = no
- frontend_changed = no
- route_changed = no
- api_route_added = no
- runtime_changed = no
- helper_called = no
- evidenceitem_write_runtime_called = no
- actual_evidence_layer_write_approved = no
- actual_evidence_layer_write_performed = no
- persisted_evidence_layer_record_created = no
- production_evidenceitem_creation_approved = no
- production_evidenceitem_created = no
- review_queue_runtime_used = no
- production_review_queue_item_created = no
- production_case_created = no
- production_analysis_run_created = no
- actual_analysis_execution_started = no
- production_analysis_result_authorized = no
- production_analysis_result_created = no
- production_analysis_result_creation_go_no_go_authorization_performed = no
- production_analysis_result_creation_final_authorization_performed = no
- source11_runtime_called = no
- finalsummaryreport_runtime_called = no
- b_end_report_runtime_generated = no
- sandbox_public_event_generated = no
- export_download_public_final_delivery_created = no
- provider_called = no
- collector_called = no
- private_collector_inspected = no
- real_exchange_dir_read = no
- production_package_rows_parsed = no
- additional_row_parsing_performed = no
- raw_rows_comments_identities_exposed = no
- secrets_read = no
- source11_update_recommended = no
- recommended_tag = no
- discussion_ready_for_protocol_tests = yes
- actual_write_ready_now = no
- production_evidenceitem_creation_ready_now = no
- selected_next_boundary_option = ready_for_9A_2_actual_evidence_layer_write_production_evidenceitem_authorization_protocol_tests_only

## Approval Interpretation

Exact approval phrase received for this phase:

`APPROVE_9A_1_ACTUAL_EVIDENCE_LAYER_WRITE_PRODUCTION_EVIDENCEITEM_GO_NO_GO_GATE_DECISION_DOCS_ONLY`

This phrase authorizes only a docs-only go/no-go gate decision for future actual Evidence Layer write / production EvidenceItem governance. It does not authorize actual Evidence Layer write, persisted Evidence Layer record creation, production EvidenceItem creation, EvidenceItem write runtime execution, Review Queue runtime, production Review Queue item creation, production case creation, production analysis_run creation, actual analysis execution, production Analysis Result authorization or creation, 8W-70 reactivation, Source 11 runtime, FinalSummaryReport runtime, B-end / Sandbox / export / public / final-delivery runtime, provider/collector jobs, private collector inspection, real exchange/package directory reads, production package-row parsing, real API/LLM calls, URL fetch, scraping, raw identity exposure, Project Source file creation, docs/project_sources creation, or GitHub Actions changes.

## Batchability Result

- can_merge = yes
- merge_scope = go/no-go decision + architecture gate contract + authorization/blocker matrix + future tests-only phrase + next-boundary recommendation
- merge_reason = all work is docs-only and planning-only; it does not cross actual Evidence Layer write, production EvidenceItem, Review Queue runtime, production case, production analysis_run, actual analysis execution, production Analysis Result, Source 11 runtime, FinalSummaryReport runtime, route/API/frontend, collector/provider runtime, real package-row, public/export delivery, or Project Source repo-file boundaries
- batch_stop_rule = stop and report if code/test/runtime/UI implementation, helper execution, actual write, production object, route/API/frontend change, real package read, private collector inspection, raw identity exposure, or privacy-sensitive access appears necessary

## Current State Summary

8Y Route C reached a controlled backend candidate/boundary chain only. The Route C line is useful as local governance evidence, but it is not production runtime.

8Y-14 controlled EvidenceItem write runtime semantics were local helper/test-path only. The 8Y-14 health report records controlled backend test-path semantics, but it also records `production_evidence_item_created = no` and `persisted_evidence_layer_record_created = no`.

8Y-16 production case candidate, 8Y-18 production analysis_run candidate, and 8Y-20 analysis result boundary/candidate are all local controlled candidate/boundary objects only. They do not create production case runtime records, production analysis_run runtime records, actual analysis execution, or production Analysis Result.

8Y-21 reconciled Route C with the 8W authorization path and selected pause. It preserved `8w69_pause_preserved = yes` and `8w70_reactivation_selected = no`.

8Z reached only the Internal Alpha review console route-consumption checkpoint: `frontend static internal shell -> read-only frontend helper -> existing disabled internal backend GET route -> safe metadata projection response / disabled fallback handling`.

8Z does not authorize actual write, Review Queue runtime, production objects, Source 11 runtime, FinalSummaryReport runtime, public/export/final delivery, or recording/video.

8W-69 production Analysis Result creation authorization chain remains paused. It did not approve go/no-go authorization, final authorization, production Analysis Result creation, actual analysis execution, production analysis_run, production case, production EvidenceItem, or Review Queue runtime.

Current default remains pause. No actual write or production EvidenceItem has been authorized.

## Interpretation of 8Y-14 / Write Candidate Evidence

8Y-14 does not authorize actual write.

The 8Y-14 controlled write helper result is only controlled backend test-path semantics. It is not persisted Evidence Layer record creation. It is not production EvidenceItem creation. It is not a precedent for automatic write. It does not satisfy human authorization requirements.

The 8Y-14 path is useful because it proved phrase-gated helper isolation, warning/manual-review preservation, and side-effect blocking under controlled test-path conditions. It is insufficient for an actual write because actual write authorization requires a separate manual protocol, explicit human authority, input lineage verification, blocker classification, risk classification, and stop-before-write validation.

## Go/No-Go Readiness Interpretation

- discussion_ready_for_protocol_tests = yes
- actual_write_ready_now = no
- production_evidenceitem_creation_ready_now = no

The project may discuss a future tests-only authorization protocol because no privacy issue was found in this docs-only review and the existing 8Y/8Z/8W chain provides enough governance context to design safety-contract tests.

The project must not perform actual write now. The current evidence does not authorize persisted Evidence Layer record creation, production EvidenceItem creation, Review Queue runtime, production case creation, production analysis_run creation, actual analysis execution, production Analysis Result creation, Source 11 runtime, FinalSummaryReport runtime, public/export/final delivery, provider/collector jobs, real package reads, or raw identity exposure.

## Authorization Option Comparison

### Option A: pause_only

Status: allowed fallback.

This is the safest default if the project does not want any 9A follow-up.

### Option B: docs-only authorization protocol expansion

Status: allowed but not preferred.

This would add more planning without implementation. It is lower risk, but 9A-1 already captures the major authorization requirements, blocker categories, and risk categories.

### Option C: authorization protocol safety contract tests-only

Status: selected next boundary.

This adds no actual write, no production EvidenceItem, and no runtime object creation. It can inspect existing helper surfaces statically or through non-writing contract checks, verify no write-ready claims, verify no direct runtime use, verify no route/API/frontend exposure, and produce a tests-only health report.

### Option D: controlled actual-write dry-run candidate

Status: not selected.

This is too close to actual write without first locking the authorization protocol through tests-only safety contracts.

### Option E: actual Evidence Layer write smoke

Status: blocked.

This requires a later human authorization protocol, exact approval phrase, blocker clearance, and validation plan.

### Option F: production EvidenceItem runtime

Status: blocked.

This crosses a high-risk production object boundary and remains outside 9A-1.

### Option G: production case / analysis_run / Analysis Result chain

Status: blocked.

Source 24 and 8W-69 pause remain preserved. The production Analysis Result chain remains separate and paused.

## Selected Next Boundary

Selected next boundary:

`ready_for_9A_2_actual_evidence_layer_write_production_evidenceitem_authorization_protocol_tests_only`

Reason: 9A-1 is not enough to write, but it is enough to define a no-write tests-only safety contract phase that can prove the project still has no active write authorization path, no production EvidenceItem path, and no route/API/frontend write exposure.

Fallback:

`pause_or_blocked_before_actual_evidence_layer_write_authorization_protocol_tests`

## Future 9A-2 Phrase Status

Inactive future phrase:

`APPROVE_9A_2_ACTUAL_EVIDENCE_LAYER_WRITE_PRODUCTION_EVIDENCEITEM_AUTHORIZATION_PROTOCOL_TESTS_ONLY`

This phrase is recorded only as inactive future tests-only wording. It does not authorize anything in 9A-1. It does not authorize actual Evidence Layer write, production EvidenceItem creation, helper execution that writes, Review Queue runtime, production case creation, production analysis_run creation, actual analysis execution, production Analysis Result creation, Source 11 runtime, FinalSummaryReport runtime, or public/export/final delivery.

## Future 9A-2 Allowed Scope If Later Approved

If separately approved later, 9A-2 may only be:

- tests-only
- static/contract safety tests only
- may inspect existing write helper surfaces
- may assert actual write remains blocked by default
- may assert no production EvidenceItem route/runtime exists
- may assert no route/API/frontend can trigger write
- may assert no Project Source files are created in repo
- no actual write
- no helper execution that writes
- no persisted record
- no production EvidenceItem
- no Review Queue runtime
- no production case
- no production analysis_run
- no actual analysis execution
- no production Analysis Result
- no Source 11 / FinalSummaryReport
- no public/export/final delivery
- no provider/collector jobs
- no real package reads
- no raw rows/comments/identities

## Future Write Authorization Protocol Requirements

Any later actual write gate must require:

- exact approval phrase for that later write phase
- explicit human authority
- manual review responsibility acceptance
- warning_count acknowledgment
- human_review_required acknowledgment
- no_automatic_trust_upgrade acknowledgment
- blocker status classification
- risk category classification
- input object lineage verification
- raw/private/secret field absence
- safe evidence identity policy
- no route/API/frontend exposure unless separately gated
- no production case/analysis_run/Analysis Result side-effect
- no Source 11 / FinalSummaryReport side-effect
- audit note
- rollback / revocation / pause handling
- validation plan
- stop before write if any blocker remains

## Future Write Input Contract Sketch

Future write input may only be discussed as:

- controlled production-import-derived write candidate or later explicitly approved write authorization object
- candidate schema versioned
- safe metadata only where possible
- no raw author identities
- no private messages or secrets
- no arbitrary file path
- no real package row parsing during authorization step
- all boundary flags explicit
- all side-effect flags false before final authorization

## Future 9A-2 Output Contract Sketch

Future tests-only 9A-2 output may only include:

- tests verify absence of write-ready implementation
- tests verify existing helpers require exact phrase and remain isolated
- tests verify no route/API/frontend write surface
- tests verify no production EvidenceItem creation path is selected
- health report records tests-only boundary
- no runtime output object except test report

## Relationship to 8W

8W-69 pause remains preserved. 8W-70 reactivation remains not selected.

9A Evidence write authorization does not satisfy production Analysis Result creation authorization protocol. Production Analysis Result remains separate and paused.

## Relationship to Source 11

9A-1 does not update Source 11. Source 11 / FinalSummaryReport runtime is not affected.

Any future Source 11 interaction remains a separate gate.

## Relationship to Review Console

8Z review console route-consumption checkpoint does not authorize write.

The review console UI must remain no-write / no-production / human-review boundary display only. No write button or approve-write CTA is allowed.

## Relationship to Recording / Video

Recording/video is not the next architecture step.

9A is governance/write authorization planning, not presentation asset work. Recording remains final presentation assets only.

## Source Update Recommendation

No immediate Project Source update after 9A-1 unless it becomes part of a larger 9A checkpoint.

Source 11 update = no.

Source 28 / 27 remain valid. Do not edit Project Source files in repo.

## Validation Scope

This phase requires docs-only validation:

- `git diff --check`
- trailing whitespace scan for the new docs
- open-marker/mojibake scan for the new docs
- 9A-1 approval phrase scan
- future 9A-2 phrase scan
- forbidden positive claim scan with matches allowed only in explicitly negative / forbidden / not-approved context
- scope scan
- `git status --short`

No pytest, frontend build, browser smoke, route smoke, collector/provider jobs, real API/LLM/network, URL fetch, or scrape is required or allowed for this docs-only go/no-go gate decision.
